Related references
Note: Only part of the references are listed.The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53
Wen-fang Li et al.
ACTA PHARMACOLOGICA SINICA (2021)
The p53/p73-p21CIP1 tumor suppressor axis guards against chromosomal instability by restraining CDK1 in human cancer cells
Ann-Kathrin Schmidt et al.
ONCOGENE (2021)
circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis
Chi Zhou et al.
MOLECULAR THERAPY (2020)
miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer
Jin-Chun Qi et al.
FRONTIERS IN ONCOLOGY (2020)
E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway
Yan Yu et al.
CELL DEATH & DISEASE (2020)
MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway
Xing Peng et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Upregulation of miR-519d-3p Inhibits Viability, Proliferation, and G1/S Cell Cycle Transition of Oral Squamous Cell Carcinoma Cells Through Targeting CCND1
Wenjie Zhang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
miR-519d-3p Overexpression Inhibits P38 and PI3K/AKT Pathway via Targeting VEGFA to Attenuate the Malignant Biological Behavior of Non-Small Cell Lung Cancer
Guangzhao Zhang et al.
ONCOTARGETS AND THERAPY (2020)
The microRNA signatures: aberrantly expressed miRNAs in prostate cancer
N. Sharma et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
Cheng Wang et al.
BMC CANCER (2019)
p53 nuclear accumulation as an early indicator of lethal prostate cancer
David I. Quinn et al.
BRITISH JOURNAL OF CANCER (2019)
Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer Cells
Qingniao Zhou et al.
ONCOTARGETS AND THERAPY (2019)
Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer
Anis A. Humid et al.
EUROPEAN UROLOGY (2019)
MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1
Dengfeng Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Friend or Foe: MicroRNAs in the p53 network
Zhenghua Luo et al.
CANCER LETTERS (2018)
miR-519d-3p Inhibits Cell Proliferation and Invasion of Gastric Cancer by Downregulating B-Cell Lymphoma 6
Yong-Yuan Li et al.
CYTOGENETIC AND GENOME RESEARCH (2018)
p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer
Xin Sui et al.
CELL DEATH & DISEASE (2018)
EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer
Laura E. Pascal et al.
NEOPLASIA (2018)
Targeted nonviral gene therapy in prostate cancer
Najla Altwaijry et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Modeling the role of microRNA-449a in the regulation of the G2/M cell cycle checkpoint in prostate LNCaP cells under ionizing radiation
Shantanu Gupta et al.
PLOS ONE (2018)
Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov et al.
NATURE REVIEWS CANCER (2018)
E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C
Xiu-Bo Sang et al.
ONCOTARGET (2017)
FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling
Qiji Li et al.
CANCER LETTERS (2017)
How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
G. Daniel Grass et al.
BIOSCIENCE REPORTS (2016)
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma
Kaifeng Qiu et al.
ARCHIVES OF ORAL BIOLOGY (2016)
E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer
Yu-Xiang Liang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
The role of CD147 expression in prostate cancer: a systematic review and meta-analysis
Yun Ye et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
CARF (Collaborator of ARF) overexpression in p53-deficient cells promotes carcinogenesis
Rajkumar S. Kalra et al.
MOLECULAR ONCOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MiR-519d-3p Suppresses Invasion and Migration of Trophoblast Cells via Targeting MMP-2
Jie Ding et al.
PLOS ONE (2015)
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer
Martina Kluth et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Propranolol Inhibits Glucose Metabolism and 18F-FDG Uptake of Breast Cancer Through Posttranscriptional Downregulation of Hexokinase-2
Fei Kang et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Loss of P53 facilitates invasion and metastasis of prostate cancer cells
Yi Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2
Francesca Fornari et al.
JOURNAL OF PATHOLOGY (2012)
EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer
Haining Zhu et al.
PROSTATE (2012)
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer
Seong O. Suh et al.
CARCINOGENESIS (2011)
Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance
H. Z. Zeng et al.
NEOPLASMA (2011)
Share Paper
